Skip to main content
. 2022 Sep 24;2022:6967573. doi: 10.1155/2022/6967573

Figure 2.

Figure 2

MiR-602 deficiency exacerbated the injury induced by OGD/R treatment on HBMECs. HBMECs were transfected with miR-602 inhibitor for 48 hours and then subjected to OGD/R treatment. (a) The relative expression level of miR-602. (b) The effect of miR-602 deficiency in ROS level in HBMECs was detected by ROS detection assay. (c) The effect of miR-602 deficiency on the viability of HBMECs was detected by CCK-8. (d) The effect of miR-602 deficiency on the apoptosis was observed by flow cytometry assay. ∗P < 0.05, ∗∗P < 0.01.